CyteFinder® II Imaging Instruments
Ultra-Sensitive Rare-Cell Detection from Liquid Biopsies
Immunofluorescence Imaging for Rare Cell Detection
CyteFinder® and AccuCyte® transform liquid biopsy by delivering unmatched sensitivity and visual confirmation of rare, nucleated cells. Together they ensure you see—and trust—every rare cell detected, enabling confident, reproducible discoveries that accelerate biomarker development, therapeutic insights, and precision medicine.
- CyteFinder II Instruments are high-speed, whole slide imaging systems optimized for multiplexed cell-based liquid biopsy analysis
- Integrated machine learning algorithm detects and rank orders candidate cells for user review
- CytePicker® Retrieval Module enables single cell retrieval from any location on the slide (CyteFinder II Instrument only)
- Robust design ideal for placement in clinical laboratories and use in clinical trials
CyteFinder II Instrument
Retrieve single cells or tissue micro-regions with the CytePicker Retrieval Module
CyteFinder II HT Instrument
Scan up to 80 slides unattended
“This technology can detect as few as one cell in a sample"
Daniel E. Sabath, MD, PhD
Professor | Head, Hematology Division, Department of Laboratory Medicine and Pathology | University of Washington
Applications include:
-
- Circulating tumor cell-based liquid biopsy
- Cell-based non-invasive prenatal testing
- Custom rare cell identification (various blood cell types)
- Clinical research for therapeutic targets
Case Study
Accurate CTC detection is critical in the recovery of useful, quantitative data from patient blood. A research article published in Frontiers in Oncology describes the AccuCyte process for CTC isolation and CyteFinder II’s immunofluorescence staining and imaging, together providing a reliable and accurate workflow at > 95% when compared to recovery rates using density or lysis-based processes.
Accurate isolation and detection of circulating tumor cells using enrichment-free multiparametric high resolution imaging
Yeo D, Kao S, Gupta R, et al. University of Sydney, Sydney, Australia
Additional Articles and Research
See CyteFinder Citations on Google Scholar →
Need Services?
RareCyte's Precision Biology™ Services enables you to unlock deep biomarker insights from every liquid biopsy sample to advance translational and clinical research. It combines milestone-based project management, a robust Quality Management System, and expert scientists who designs custom assays and manage complex workflows to help you identify therapy responders in clinical trials or help identify patients most likely to benefit.